Linagliptin 2.5 mg

Voglibose (0.3mg)

Price 60.0 INR / Piece

Minimum Order Quantity : 1 Number

Physical Form : Tablets

Storage Instructions : Keep dry & cool place

Dosage Guidelines : As Per Instructions

Ingredients : Voglibose (0.3mg)

Gliclazide SR 60mg & Dapagliflozin 10mg Tablets

Price 329.0 INR / Unit

Minimum Order Quantity : 1 Unit

Physical Form : Tablets

Storage Instructions : Store in a cool, dry place below 30 C.

Ingredients : GLICLAGLAZE DAPA 6010 is a combination oral antidiabetic medication containing Gliclazide SR 60 mg and Dapagliflozin 10 mg, developed for the effective management of Type 2 Diabetes Mellitus in adults. This dualaction therapy helps achieve better blood glucose control when diet, exercise, and singledrug therapy are not sufficient. Gliclazide SR is a sulfonylurea that stimulates the pancreas to release insulin, while Dapagliflozin is an SGLT2 inhibitor that removes excess glucose through the urine by preventing its reabsorption in the kidneys. The sustainedrelease (SR) formulation of Gliclazide provides prolonged blood sugar control throughout the day. When combined with a healthy lifestyle, GLICLAGLAZE DAPA 6010 helps improve glycemic control and reduces the risk of longterm diabetesrelated complications. Uses GLICLAGLAZE DAPA 6010 is commonly prescribed for: Management of Type 2 Diabetes Mellitus Improving blood glucose control alongside diet and exercise Lowering fasting and postmeal blood sugar levels Supporting longterm diabetes management Helping reduce the risk of diabetesrelated complications through effective glycemic control Benefits GLICLAGLAZE DAPA 6010 offers dualaction blood sugar control with complementary mechanisms. Effectively lowers fasting and postprandial blood glucose levels Stimulates insulin release from the pancreas Promotes elimination of excess glucose through urine Helps improve HbA1c levels Sustainedrelease formulation provides prolonged glucose control Supports healthy weight management when combined with lifestyle modifications May contribute to cardiovascular and kidney health benefits associated with SGLT2 inhibitor therapy in appropriate patients Helps reduce the risk of longterm diabetic complications affecting the eyes, kidneys, nerves, and heart Dosage Take GLICLAGLAZE DAPA 6010 exactly as prescribed by your healthcare provider. The tablet is generally taken once daily with breakfast or the first main meal of the day. Swallow the sustainedrelease tablet whole with a glass of water without crushing, chewing, or breaking it. Follow your prescribed diabetic diet, maintain regular physical activity, and monitor your blood glucose levels as advised. Do not skip meals while taking this medicine, as doing so may increase the risk of hypoglycemia. Continue treatment regularly unless instructed otherwise by your physician. Side Effects Like all medicines, GLICLAGLAZE DAPA 6010 may cause side effects, although not everyone experiences them. Common side effects include: Low blood sugar (hypoglycemia) Frequent urination Increased thirst Urinary tract infection Genital fungal infections Dizziness Headache Nausea Mild stomach discomfort Seek immediate medical attention if you experience severe hypoglycemia, allergic reactions, diabetic ketoacidosis, dehydration, or persistent unusual symptoms. Precautions and Warnings Before taking GLICLAGLAZE DAPA 6010, inform your doctor if you have kidney disease, liver disease, heart failure, dehydration, recurrent urinary tract infections, or a history of severe hypoglycemia. Regular monitoring of blood glucose, HbA1c, and kidney function is recommended during treatment. Stay well hydrated, as Dapagliflozin increases urinary glucose excretion and may lead to dehydration. Limit alcohol consumption because it may increase the risk of hypoglycemia. Pregnant and breastfeeding women should use this medicine only if advised by their healthcare provider. Inform your physician about all prescription medicines, overthecounter drugs, and herbal supplements to avoid possible drug interactions. Conclusion GLICLAGLAZE DAPA 6010 (Gliclazide SR 60 mg & Dapagliflozin 10 mg Tablets) is an effective dualcombination therapy for adults with Type 2 Diabetes Mellitus requiring improved blood sugar control. By combining sustained insulin release with enhanced urinary glucose elimination, it helps achieve better glycemic control, improves HbA1c levels, and supports longterm diabetes management. When used as directed along with a balanced diet, regular exercise, and routine medical monitoring, GLICLAGLAZE DAPA 6010 helps reduce the risk of diabetesrelated complications and promotes better overall health and quality of life.

Sitagliptin Metformin

Price 278.00 INR / Piece

Minimum Order Quantity : 1 Piece

Physical Form : Tablets

Storage Instructions : Keep dry & cool place

Dosage Guidelines : As Per Instructions

Ingredients : Sitagliptin Metformin

Apixaban (2.5mg)

Price 108.5 INR

Minimum Order Quantity : 1 Pieces

Physical Form : Tablets

Storage Instructions : Cool and dry place

Dosage Guidelines : Direction by physician